Biotech Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million August 28, 2026
Biotech HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma August 27, 2026
Biotech AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease August 26, 2026
Biotech Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases August 26, 2026
Biotech Biohaven and SK Biopharmaceuticals Enter into Strategic Global Licensing Agreement for Novel Kv7 Ion Channel Platform and Opakalim, Lead Candidate for Epilepsy August 26, 2026
Biotech Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options August 25, 2026
Biotech CAPR Investor Losses: Capricor Therapeutics Clinical Data Announcement and Corresponding 64% Stock Drop Trigger Securities Class Action for Investors August 25, 2026
Biotech First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis August 24, 2026
Biotech Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 20, 2026
Search
Biotech
August 28, 2026
August 27, 2026
August 26, 2026
August 26, 2026
August 26, 2026
August 26, 2026
August 25, 2026
August 25, 2026
August 24, 2026
August 20, 2026
